Sea Crest Wealth Management, LLC Gilead Sciences, Inc. Transaction History
Sea Crest Wealth Management, LLC
- $874 Million
- Q2 2025
A detailed history of Sea Crest Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 6,527 shares of GILD stock, worth $741,336. This represents 0.08% of its overall portfolio holdings.
Number of Shares
6,527
Previous 6,581
0.82%
Holding current value
$741,336
Previous $737,000
1.9%
% of portfolio
0.08%
Previous 0.09%
Shares
31 transactions
Others Institutions Holding GILD
# of Institutions
2,329Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$13.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$13.6 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.72 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.26 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.26 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $142B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...